It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
The swine flu outbreak is likely to benefit one of the most prolific and successful venture capital firms in the United States: Kleiner Perkins Caufield & Byers, Thomson Reuters Private Equity Week reported on Friday.
Shares of two public companies in the firm's portfolio of eight Pandemic and Bio Defense companies BioCryst Pharmaceuticals (BCRX.O) and Novavax (NVAX.O) jumped Friday on news that the swine flu killed a reported 60 people in Mexico and has infected people in the United States
Vaccines from Roche, which sells Tamiflu, and GSK, maker of Relenza, have been shown to work against viral samples of the new disease. The drugs were also used to help protect against outbreaks of bird flu in Asia, providing windfall profits for the companies.